Infectious complications in head and neck cancer patients treated with cetuximab: propensity score and instrumental variable analysis.

BACKGROUND: To compare the infection rates between cetuximab-treated patients with head and neck cancers (HNC) and untreated patients. METHODOLOGY: A national cohort of 1083 HNC patients identified in 2010 from the Taiwan National Health Insurance Research Database was established. After patients we...

Full description

Bibliographic Details
Main Authors: Ching-Chih Lee, Hsu-Chueh Ho, Shih-Hsuan Hsiao, Tza-Ta Huang, Hon-Yi Lin, Szu-Chin Li, Pesus Chou, Yu-Chieh Su
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3509146?pdf=render